GENETECH PHARMACEUTICALS LIMITED
Significant control: Luke Henry Lowrie (25–50%), Emma Lowrie (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Genetech Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Genetech Pharmaceuticals Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
GENETECH PHARMACEUTICALS LIMITED is an active private limited company (company number 12370221) incorporated on 18 December 2019, registered in Watford. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 31 March 2025, showing net assets of £714k and cash of £672k, with 8 employees on average. Net assets rose 100% on the prior period (£356k).
By net assets it sits in the top quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).
Ownership and control
- Mr Luke Henry Lowrie
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs. Emma Lowrie
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Senju Capital Limited
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Ms Leah Violet Wallhead
- owns 25–50% of shares
- holds 25–50% of voting rights
- Emerging Medical Technologies Limited
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 18 December 20196 yrs ago
- Next accounts due
- 31 December 2026in 64 days
- Confirmation statement due
- 1 January 2027in 65 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £714k | £672k | £662k | — | — | — | 8 |
| 31 March 2024 | £356k | £552k | £1.05m | — | — | — | 8 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £714,422 at 31 March 2025
- Net assets up 10% or more on the prior period+100.5% vs prior period
- Cash at bank of £50,000 or moreCash £671,698
- Incorporated five or more years agoIncorporated 18 December 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 65 days
- Next accounts duein 64 days
- Accounts period endNet assets £714k · small accounts
- Accounts period endNet assets £356k · small accounts
- Incorporated
Similar companies in Greater London
- PHARMEDEX HEALTHCARE LIMITEDAddlestone · inc. Dec 2019
- EPSILON SERVICES LIMITEDRuislip · inc. Dec 2019
- GREENLIGHT MEDICARE LTDWatford · inc. Nov 2019
- PLIRIS HEALTHCARE UK LTDWatford · inc. Nov 2019
- INTERNATIONAL MEDICAL SUPPLIES LTDWeybridge · inc. Jan 2020
- DEVALIA HOLDINGS LIMITEDChislehurst · inc. Nov 2019
All companies incorporated on 18 December 2019 · in Dec 2019.
Reminders for GENETECH PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.